Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Triamcinolone Acetonide Ointment USP, 0.5%, the generic version of Triamcinolone Acetonide Ointment USP, 0.5% of Perrigo New York, Inc.
According to IMS Health sales data for the 12 month period ending May 2016, the Triamcinolone Acetonide Ointment USP, 0.5% market' achieved annual sales of approximately USD 4.4 million.
Shares of the company gained Rs 0.8, or 0.09%, to trade at Rs 865.90. The total volume of shares traded was 17,264 at the BSE (1.16 p.m., Monday).